How much is Jnana Therapeutics worth in 2026?

Jnana Therapeutics has a current valuation of N/A based on their Later Stage VC (Series C1) round and secondary market data.

How much funding has Jnana Therapeutics raised?

Jnana Therapeutics has raised N/A in total funding across 2 funding rounds.

Jnana Therapeutics

Drug Discovery

Jnana Therapeutics valuation and funding history | Last updated: November 15, 2022 | 2 funding rounds

Current Valuation

N/A

As of November 15, 2022

Total Funding Raised

N/A

Across 2 rounds

Last Round

Later Stage VC (Series C1)

$107.0M

Last Funding

Nov 2022

Funding date

Capital Efficiency

N/A

Valuation / Funding

Funding History & Valuation Timeline

Complete history of all funding rounds and valuation milestones

Date	Round	Amount	Post-Valuation	Growth
November 15, 2022	Later Stage VC (Series C1)	$107.0M	N/A	-
August 18, 2021	Early Stage VC (Series B)	$50.0M	N/A	-

Valuation Analysis

Current Valuation Metrics

Jnana Therapeutics is currently valued at N/A as of November 15, 2022.

Track Jnana Therapeutics Valuation Updates

Get notified when Jnana Therapeutics raises new funding or valuation changes

Explore More Data

Detailed analysis for Jnana Therapeutics

Secondary Market Price

Real-time pricing data and trends

Valuation Tracker

Historical valuation changes

Funding History

Complete funding round timeline

Secondary Price History

Historical transaction data

All Investors

Complete list of all investors

View 5 companies free

Create a free account to unlock Jnana Therapeutics's valuation history, funding rounds, and growth metrics.

No credit card required

What is Jnana Therapeutics Worth in 2026?

Jnana Therapeutics is a leading private company in the Drug Discovery sector. Track Jnana Therapeutics's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.

How Jnana Therapeutics Valuation is Determined

Private company valuations like Jnana Therapeutics's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.